MyFinsight
Home
Blog
About
Contact
Download
Download image
Maturity of short-term
investments
$337,913K
Proceeds from sale of
property, plant and...
$155K
Net cash provided by
investing activities
$134,290K
Canceled cashflow
$203,778K
Net (decrease)
increase in cash and cash...
-$25,743K
Canceled cashflow
$134,290K
Stock-based compensation
expense
$26,234K
Amortization (accretion) on
short-term investments
-$3,956K
Non-cash operating lease
expense
$3,277K
Prepaid expenses and
other current assets
-$2,541K
Loss on
extinguishment of debt
-$1,828K
Depreciation expense
$1,696K
Other non-current
assets
-$43K
Proceeds from issuances
of common stock...
$570K
Purchase of short-term
investments
$203,404K
Purchase of property and
equipment
$374K
Net cash used in
operating activities
-$128,336K
Canceled cashflow
$39,575K
Net cash (used in)
provided by financing...
-$31,697K
Canceled cashflow
$570K
Net loss
-$149,344K
Accrued liabilities
-$12,167K
Accounts payable
-$5,480K
Operating lease
liabilities
-$876K
Gain on sale of
property plant and...
$44K
Payment of debt
$32,267K
Back
Back
Cash Flow
source: myfinsight.com
PLIANT THERAPEUTICS, INC. (PLRX)
PLIANT THERAPEUTICS, INC. (PLRX)